Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size

Does Green Tea Affect Postprandial Glucose, Insulin and Satiety in Healthy Subjects

This study has been completed.
Sponsor:
Information provided by:
Skane University Hospital
ClinicalTrials.gov Identifier:
NCT01086189
First received: March 11, 2010
Last updated: NA
Last verified: December 2009
History: No changes posted
  Purpose

Green tea consumption could lower the risk of type II diabetes, as suggested by epidemiological studies. There is also evidence from intervention studies that green tea can decrease blood glucose levels and contribute to weight loss.

The aim with this study is therefore to examine the postprandial effects of green tea on glycemic index, insulin levels and satiety in healthy individuals after the consumption of a meal.


Condition
Diabetes Type 2
Obesity

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Cross-Sectional

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Skane University Hospital:

Primary Outcome Measures:
  • Postprandial glucose and insulin

Secondary Outcome Measures:
  • Postprandial satiety
Enrollment: 14
Study Start Date: December 2009
Study Completion Date: February 2010
Detailed Description:

The study was conducted on 14 healthy volunteers, with a crossover design. Participants were randomized to either green tea or water. This was consumed together with a breakfast consisting of white bread. Blood samples were drawn at 0, 15, 30, 45, 60, 90 and 120 minutes. Participants completed two different satiety scores at the same time intervals.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

14 healthy volunteers

Criteria

Inclusion Criteria:

  • Healthy subjects

Exclusion Criteria:

  • Diabetes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01086189

Locations
Sweden
Skane University Hospital
Malmo, Skane, Sweden, 205 02
Sponsors and Collaborators
Skane University Hospital
  More Information

No publications provided by Skane University Hospital

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT01086189     History of Changes
Other Study ID Numbers: 2009/66
Study First Received: March 11, 2010
Last Updated: March 11, 2010
Health Authority: Sweden: Regional Ethical Review Board

ClinicalTrials.gov processed this record on March 02, 2015